Improving blood sugar control during exercise for people with Type 1 diabetes
Limiting Dysglycemia Around Physical Activity for People with Type 1 Diabetes Using Activity-Aware Automated Insulin Delivery – the APEX Project.
This research aims to help people with Type 1 diabetes manage their blood sugar better when they are physically active, using a smart insulin delivery system.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11135506 on NIH RePORTER |
What this research studies
Many people with Type 1 diabetes find it challenging to exercise due to worries about low blood sugar or the need for careful planning. This research is developing new ways for an automated insulin delivery system, called APEX, to adjust insulin automatically before, during, and after physical activity. It considers how insulin sensitivity changes after exercise, the lasting effects of previous activity, and even predicts future activity patterns. The goal is to make it easier for you to be spontaneous with your exercise without constantly thinking about your insulin.
Who could benefit from this research
Good fit: Ideal candidates would be individuals with Type 1 diabetes who use or are candidates for automated insulin delivery systems and engage in physical activity.
Not a fit: Patients who do not have Type 1 diabetes or do not use automated insulin delivery systems would not directly benefit from this specific technology.
Why it matters
Potential benefit: If successful, this could allow people with Type 1 diabetes to exercise more freely and safely, improving their overall health and quality of life.
How similar studies have performed: This project tests novel approaches within an existing, well-established automated insulin delivery system developed by a center with a strong track record in diabetes technology and clinical trials.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Breton, Marc D — University of Virginia
- Study coordinator: Breton, Marc D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.